pyrvinium has been researched along with Cardiomyopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gupta, K; Kumari, A; Pandey, S; Sen, P; Singh, G; Singh, R | 1 |
1 other study(ies) available for pyrvinium and Cardiomyopathies
Article | Year |
---|---|
Wnt/β-Catenin Antagonist Pyrvinium Exerts Cardioprotective Effects in Polymicrobial Sepsis Model by Attenuating Calcium Dyshomeostasis and Mitochondrial Dysfunction.
Topics: Animals; beta Catenin; Calcium; Cardiomyopathies; Coinfection; Cytokines; Disease Models, Animal; Fibrosis; Inflammation Mediators; Male; Mitochondria, Heart; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Necrosis; Oxidative Stress; Pyrvinium Compounds; Rats, Wistar; Sepsis; Ventricular Function, Left; Ventricular Pressure; Wnt Signaling Pathway | 2021 |